In lung cancer cells, an increased level of FRA1 can inhibit p53 and increase the level of its negative regulator MDM2, ultimately suppressing apoptosis of lung cancer cells by increasing apoptosis-related mitochondrial membrane potential (ΔΨm) and suppressing intracellular ROS and aggregation of Ca2+ [20]. The gene discussed is TP53; the disease is lung carcinoma.